title: A novel method to induce nicotine dependence by intermittent drug delivery using osmotic minipumps.
abstract: Although osmotic minipumps are a reliable method for inducing nicotine dependence in rodents, continuous nicotine administration does not accurately model the intermittent pattern of nicotine intake in cigarette smokers. Our objectives, therefore, were to investigate whether intermittent nicotine delivery via osmotic minipumps could induce dependence in rats, and to compare the magnitude and duration of withdrawal following forced abstinence from intermittent nicotine to that induced by continuous nicotine administration. In order to administer nicotine intermittently, rats were surgically implanted with saline-filled osmotic minipumps attached to polyethylene tubing that contained hourly unit doses of nicotine alternating with mineral oil to mimic "injections". Three doses of nicotine (1.2, 2.4, and 4.8mg/kg/day) and saline were administered for 14days using this method. In order to compare our intermittent delivery method with the more traditional continuous nicotine delivery, a second group of rats was implanted with minipumps attached to tubing that delivered continuous nicotine for 14days. Rats were administered a 1.5mg/kg subcutaneous (SC) mecamylamine challenge and observed for somatic signs of withdrawal on days 7, 14, 21, and 28 following minipump implantation. Fifteen somatic withdrawal signs were summed within a 50-minute observation period to obtain a composite Dependence Score. A generalized linear mixed-effects model revealed a significant Day×Dose×Method interaction. Amongst continuously-treated rats, only 4.8mg/kg/d nicotine resulted in dependence scores significantly greater than those of controls at 14days of exposure. In contrast, all intermittent nicotine groups showed significantly higher scores beginning at 7days of exposure and persisting beyond 7days of abstinence. In general, intermittent delivery produced a more robust withdrawal syndrome than continuous delivery, and did so at a lower dose threshold and with greater persistence after forced abstinence.
authors.affiliation: Neuroimaging Research Branch, National Institute on Drug Abuse, Intramural Research Program, 251 Bayview Blvd., Suite 200, Baltimore, MD, USA.
authors.forename: Julia K
authors.initials: JK
authors.lastname: Brynildsen
authors.affiliation: Neuroimaging Research Branch, National Institute on Drug Abuse, Intramural Research Program, 251 Bayview Blvd., Suite 200, Baltimore, MD, USA.
authors.forename: Julie
authors.initials: J
authors.lastname: Najar
authors.affiliation: Neuroimaging Research Branch, National Institute on Drug Abuse, Intramural Research Program, 251 Bayview Blvd., Suite 200, Baltimore, MD, USA.
authors.forename: Li-Ming
authors.initials: LM
authors.lastname: Hsu
authors.affiliation: Neuroimaging Research Branch, National Institute on Drug Abuse, Intramural Research Program, 251 Bayview Blvd., Suite 200, Baltimore, MD, USA.
authors.forename: D Bruce
authors.initials: DB
authors.lastname: Vaupel
authors.affiliation: Neuroimaging Research Branch, National Institute on Drug Abuse, Intramural Research Program, 251 Bayview Blvd., Suite 200, Baltimore, MD, USA.
authors.forename: Hanbing
authors.initials: H
authors.lastname: Lu
authors.affiliation: Neuroimaging Research Branch, National Institute on Drug Abuse, Intramural Research Program, 251 Bayview Blvd., Suite 200, Baltimore, MD, USA.
authors.forename: Thomas J
authors.initials: TJ
authors.lastname: Ross
authors.affiliation: Neuroimaging Research Branch, National Institute on Drug Abuse, Intramural Research Program, 251 Bayview Blvd., Suite 200, Baltimore, MD, USA.
authors.forename: Yihong
authors.initials: Y
authors.lastname: Yang
authors.affiliation: Neuroimaging Research Branch, National Institute on Drug Abuse, Intramural Research Program, 251 Bayview Blvd., Suite 200, Baltimore, MD, USA. Electronic address: EStein@intra.nida.nih.gov.
authors.forename: Elliot A
authors.initials: EA
authors.lastname: Stein
mesh_terms: D016503:Drug Delivery Systems / Q000295:instrumentation*; D008464:Mecamylamine / Q000008:administration & dosage; D009995:Osmosis; D013375:Substance Withdrawal Syndrome; D014029:Tobacco Use Disorder
chemical_list: D008464:Mecamylamine
keywords: Mecamylamine HCl; Nicotine; Nicotine dependence; Nicotine withdrawal; Osmotic minipump